Quantum BioPharma
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
55 University Ave Suite 1003, Toronto, O...Phone Number
(833) 571-1811Website
www.quantumbiopharma.comRevenue
$5.7 MillionIndustry
About Quantum BioPharma
Quantum BioPharma Org Chart
Vice President, Clinical and Scientific Affai...
Vice President, Quality Systems
Is Quantum BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Quantum BioPharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Quantum BioPharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Quantum BioPharma
Website visits: Recent activity has been detected on your website
Quantum BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Quantum BioPharma recently announced quarterly report
Check if Quantum BioPharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Quantum BioPharma is spiking on competitors!
Product Launch: Get notified when Quantum BioPharma launches new products
Recommended Actions
Reach out to Masked Content who joined Quantum BioPharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Quantum BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Quantum BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Quantum BioPharma.
Quantum BioPharma financials insights
Gather financial insights about Quantum BioPharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Share Placement
$5M
Most Recent Scoops
Quantum BioPharma News & Media
Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial
TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum" or the "Company"), has reported its financial and operational results for the second quarter of 2026, ended June 30, 2026.Quantum BioPharma Announces Closing of Debt Settlement
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.Quantum BioPharma Announces Intention to Settle Debt
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.Quantum BioPharma Provides Corporate Update
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Quantum BioPharma
Quantum BioPharma Ltd. is a biopharmaceutical company that researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its mission is to develop novel solutions for b... Read More